Introduction Ipilimumab is a fully human monoclonal antibody classified under immune checkpoint inhibitors. It plays a pivotal role in cancer immunotherapy by targeting cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), a regulatory molecule that downregulates immune responses. By blocking CTLA-4, ipilimumab enhances T-cell activation and proliferation, leading to a more robust antitumor immune response. It has been … Read more
Introduction Rivaroxaban is an oral anticoagulant belonging to the class of direct Factor Xa inhibitors. It is commonly prescribed for the prevention and treatment of thromboembolic disorders such as deep vein thrombosis (DVT), pulmonary embolism (PE), and stroke prevention in non-valvular atrial fibrillation. Unlike warfarin, rivaroxaban has a predictable pharmacokinetic profile and does not require … Read more
Introduction Phenytoin is a first-generation anticonvulsant and hydantoin derivative widely utilized for the management of generalized tonic-clonic seizures, complex partial seizures, and status epilepticus. It also has historical use in certain cardiac arrhythmias. Known for its narrow therapeutic index, phenytoin requires careful dosing and monitoring, yet remains a mainstay in epilepsy therapy due to its … Read more
Mechanism of Action of Miralax Introduction Miralax, with the active ingredient polyethylene glycol 3350 (PEG 3350), is a commonly used osmotic laxative indicated for the treatment of occasional constipation. Its popularity stems from its non-stimulant mechanism, gentle action on the gastrointestinal tract, and favorable safety profile. Miralax does not cause dependency and is generally well-tolerated, … Read more
Introduction Roflumilast is an oral selective phosphodiesterase-4 (PDE4) inhibitor used in the long-term management of severe chronic obstructive pulmonary disease (COPD) associated with chronic bronchitis. Unlike bronchodilators that target airway smooth muscle, roflumilast works primarily through anti-inflammatory mechanisms. Its distinct pharmacological action makes it a valuable adjunct in reducing the frequency of exacerbations in COPD … Read more
Hyderabad has strengthened its position as one of the world’s leading centers for life sciences manufacturing, driven by robust pharmaceutical production, biotechnology advancements, and strong government-industry collaboration. Industry experts say the city’s rapid growth reflects its ability to meet global demand for medicines, vaccines, and advanced therapeutic solutions. According to recent data, Hyderabad accounts for … Read more
Introduction Desmopressin (1-deamino-8-D-arginine vasopressin; DDAVP) is a synthetic analogue of the natural antidiuretic hormone vasopressin. It exhibits strong antidiuretic properties with minimal vasopressor activity, which makes it an effective and safer alternative in treating disorders involving water balance and bleeding diatheses. Its high affinity for V2 receptors and negligible action on V1 receptors differentiates it … Read more
Introduction Atomoxetine is a selective norepinephrine reuptake inhibitor (NRI) approved for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD). It is a non-stimulant alternative to conventional stimulants like methylphenidate and amphetamines, especially beneficial for patients at risk of substance abuse or with contraindications to stimulants. Mechanism of Action (Stepwise) Pharmacokinetics Clinical Uses Adverse Effects Comparative Analysis Feature … Read more
The pharmacy admission process in Gujarat has faced yet another setback, with authorities announcing additional delays for the 2024 academic year. This latest postponement has sparked anxiety among aspiring pharmacy students and raised concerns among educational institutions that rely on a timely admissions calendar to ensure a smooth start to classes. According to state officials, … Read more
India’s pharmacy sector is set to experience a digital transformation as the Pharmacy Council of India (PCI) teams up with technology provider Dexian to modernize how the industry is regulated and managed. This initiative is expected to streamline professional governance, improve transparency, and ultimately benefit both pharmacists and the public they serve. The PCI, the … Read more
